Non-Invasive Ventilators Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (Non-invasive Positive Pressure Ventilators {PPV} and Non-invasive Negative Pressure Ventilators {NPV}), By Application (COPD and Asthma, Respiratory Distress Syndrome, and Others), By End User (Hospitals & Clinics, Ambulatory Care Centers, Others), By Region and Competition, 2021-2031F

Forecast Period	2027-2031
Market Size (2025)	USD 3.27 Billion
CAGR (2026-2031)	5.51%
Fastest Growing Segment	Hospitals & Clinics
Largest Market	North America
Market Size (2031)	USD 4.51 Billion

Market Overview

The Global Non-Invasive Ventilators Market will grow from USD 3.27 Billion in 2025 to USD 4.51 Billion by 2031 at a 5.51% CAGR. Non-invasive ventilators are specialized medical devices that deliver positive airway pressure through a mask or nasal interface, assisting ventilation without the need for invasive endotracheal intubation. The market is primarily propelled by the rising global prevalence of chronic respiratory disorders, such as Chronic Obstructive Pulmonary Disease, and an aging population increasingly susceptible to respiratory failure. Furthermore, the strategic transition toward home-based care models to minimize hospital readmissions and operational costs is generating substantial demand for these therapeutic solutions.

Despite these drivers, the market faces a significant challenge regarding the scarcity of skilled healthcare professionals required to manage these complex devices. According to the American Association for Respiratory Care, in 2024, 87% of respiratory care executives recognized a present shortage of respiratory therapists, a deficiency that severely limits patient access to effective non-invasive ventilation therapy and impedes broader market scalability across acute and home care settings.

Key Market Drivers

The escalating incidence of chronic respiratory conditions, compounded by deteriorating air quality, serves as a primary catalyst for the adoption of non-invasive ventilation systems. As urbanization intensifies, long-term exposure to particulate matter accelerates the onset of Chronic Obstructive Pulmonary Disease, necessitating consistent respiratory support. This environmental burden significantly expands the patient pool requiring therapeutic interventions. According to the American Lung Association, April 2024, in the 'State of the Air 2024' report, approximately 131.2 million individuals in the United States live in areas with unhealthy levels of ozone or particle pollution, a factor directly correlating with increased respiratory morbidity. Consequently, healthcare providers are prioritizing non-invasive modalities to manage these pulmonary challenges efficiently.

Concurrently, technological innovation aimed at home-based care is reshaping the competitive landscape. Manufacturers are developing compact, cloud-connected devices that facilitate remote patient monitoring, thereby reducing the frequency of hospital visits. This shift is validated by recent financial performance; according to Fisher & Paykel Healthcare, May 2024, in the 'Annual Report 2024', operating revenue for the Homecare product group increased by 18% over the prior year, highlighting the surging demand for out-of-hospital ventilation solutions. These advancements drive overall market revenue. For instance, according to ResMed, August 2024, in the 'Fourth Quarter Fiscal Year 2024 Results' press release, quarterly revenue grew by 9% to $1.22 billion, underscoring the robust growth of the respiratory care sector.

Download Free Sample Report

Key Market Challenges

The acute scarcity of skilled healthcare professionals stands as a formidable barrier to the expansion of the Global Non-Invasive Ventilators Market. While demand for devices rises, the effective application of non-invasive positive pressure ventilation relies heavily on the clinical expertise of respiratory therapists to manage mask leaks, titrate pressures, and ensure patient synchrony. A lack of trained personnel results in suboptimal therapy delivery and increased failure rates, causing healthcare providers to limit their investment in new equipment fleets. Consequently, the hardware market is constrained not by a lack of patient need, but by the unavailability of the specialized workforce required to operate the technology safely.

This workforce deficit specifically undermines the strategic shift toward home-based care, as there are insufficient clinicians to monitor patients outside of the hospital setting. The gap between the growing patient population and the available workforce is widening, limiting the scalability of these therapies. According to the National Board for Respiratory Care, in 2024, a total of 13,065 new credentials were awarded to practitioners, a figure that falls short of the recruitment levels necessary to replace retiring staff and accommodate the surging prevalence of respiratory pathologies.

Key Market Trends

The Integration of Artificial Intelligence for Adaptive Pressure Delivery is revolutionizing the sector by enabling devices to autonomously adjust airflow based on real-time patient breathing patterns. These advanced algorithms enhance patient-ventilator synchrony and improve treatment efficacy for complex respiratory conditions, effectively moving the technology beyond simple monitoring to active, automated therapy optimization. This shift reduces the manual burden on clinicians and ensures precise respiratory support tailored to immediate physiological needs. The accelerating adoption of these intelligent, algorithm-driven solutions is significantly boosting manufacturer performance. According to ResMed, August 2025, in the 'Form 10-K Annual Report', net revenue for the Sleep and Breathing Health business increased by 10% to $4.5 billion, a growth trajectory primarily driven by the expanding global uptake of their digital health and adaptive therapeutic platforms.

Concurrently, the market is witnessing significant Advancements in Neonatal-Specific Non-Invasive Interfaces designed to mitigate the risks associated with invasive intubation in premature infants. Innovations in ergonomic nasal masks and specialized prongs are critical in reducing skin trauma and preventing long-term complications such as bronchopulmonary dysplasia, thereby encouraging the early adoption of non-invasive support in neonatal intensive care units. This focus on protecting vulnerable pediatric patients with specialized hardware is generating robust demand for high-end critical care solutions. According to Dräger, March 2025, in the 'Annual Report 2024', Earnings Before Interest and Taxes (EBIT) rose by 16.6% to EUR 194.0 million, a financial success attributed to the sustained high demand for their comprehensive medical technology portfolio, including their leading neonatal ventilation technologies.

Segmental Insights

Market analysis identifies Hospitals and Clinics as the fastest-growing segment within the Global Non-Invasive Ventilators Market. This accelerated expansion is primarily driven by the increasing volume of patient admissions for acute respiratory failure and chronic obstructive pulmonary disease. Healthcare institutions are heavily investing in non-invasive technologies to mitigate the risks associated with invasive intubation, such as hospital-acquired pneumonia. Additionally, the rapid development of critical care infrastructure and favorable reimbursement policies for in-patient respiratory procedures further stimulate the robust demand for these devices in clinical settings.

Regional Insights

North America maintains a leading position in the global non-invasive ventilators market, driven principally by the high prevalence of respiratory conditions such as chronic obstructive pulmonary disease and sleep apnea. The region benefits from a well-established healthcare infrastructure and the strategic presence of major medical device manufacturers. Furthermore, supportive regulatory frameworks provided by the U.S. Food and Drug Administration facilitate product approvals, ensuring the availability of effective treatments. This dominance is reinforced by favorable reimbursement policies from the Centers for Medicare & Medicaid Services, which significantly enhance patient access to respiratory care solutions.

Recent Developments

• In November 2024, Fisher & Paykel Healthcare launched the F&P Nova Micro, the company’s lightest and most compact nasal pillows mask, in the United States market. Weighing less than 40 grams, the mask featured a minimal design with soft, inflatable cushions that conform to the patient’s nostrils to ensure stability and freedom of movement. The Vice President of Sales and Marketing for North America at Fisher & Paykel Healthcare remarked that the product was engineered to minimize bulk and provide a natural sleep experience. This release expanded the company’s portfolio of non-invasive interfaces, catering to patients seeking unobtrusive respiratory support options.
• In February 2024, ResMed launched the AirCurve 11 series, a bilevel positive airway pressure device intended for sleep apnea patients who require higher pressure support than standard CPAP machines provide. This system integrated advanced digital health algorithms to adaptively align with a user’s natural breathing patterns, thereby enhancing comfort and treatment adherence. The platform enabled seamless data transmission to the cloud, allowing clinicians to remotely monitor therapy progress and adjust settings as needed. The leadership team at ResMed stated that this innovation aimed to provide personalized care options that assist patients in maintaining effective long-term respiratory therapy.
• In January 2024, Getinge introduced the Servo-air Lite, a compact turbine-driven ventilator engineered specifically for non-invasive ventilation and high-flow oxygen therapy. The device was designed to operate independently of wall gas supplies, utilizing a powerful battery system that facilitated safe intrahospital transport for spontaneously breathing patients. The company emphasized that this addition to the established Servo family aimed to deliver intensive care quality performance with enhanced ease of use for clinical staff. The President of Acute Care Therapies at Getinge noted that the launch significantly expanded their ability to serve the non-invasive hospital segment with reliable and mobile respiratory solutions.
• In January 2024, Dräger collaborated with the medical technology company STIMIT to initiate a clinical trial in the United States investigating a non-invasive approach to preserving diaphragm thickness during mechanical ventilation. The research focused on using electromagnetic fields to stimulate the phrenic nerve and activate the diaphragm, aiming to prevent ventilator-induced diaphragmatic dystrophy. This trial represented a significant step in developing non-invasive therapeutic technologies that could operate alongside standard ventilation to improve patient outcomes. The study was designed to evaluate the safety and efficacy of this novel method for patients requiring prolonged respiratory support.

Key Market Players

• ResMed Inc.
• Teleflex Incorporated
• Hamilton Bonaduz AG
• Heyer medical AG
• Koninklijke Philips N.V.
• Airon Corporation
• Fisher & Paykel Healthcare Limited
• Mindray Medical International Limited
• Phoenix Medical Systems Pvt. Ltd.
• Smiths Group plc

By Product	By Application	By End User	By Region
Non-invasive Positive Pressure Ventilators {PPV} and Non-invasive Negative Pressure Ventilators {NPV}	COPD and Asthma Respiratory Distress Syndrome Others	Hospitals & Clinics Ambulatory Care Centers Others	North America Europe Asia Pacific South America Middle East & Africa

Report Scope:

In this report, the Global Non-Invasive Ventilators Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Non-Invasive Ventilators Market, By Product:

• Non-invasive Positive Pressure Ventilators {PPV} and Non-invasive Negative Pressure Ventilators {NPV}

• Non-Invasive Ventilators Market, By Application:

• COPD and Asthma
• Respiratory Distress Syndrome
• Others

• Non-Invasive Ventilators Market, By End User:

• Hospitals & Clinics
• Ambulatory Care Centers
• Others

• Non-Invasive Ventilators Market, By Region:

• North America
• United States
• Canada
• Mexico
• Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE